Follow this preprint
Comparative effects of sodium glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP4) inhibitors on new-onset atrial fibrillation and stroke outcomes
Sharen Lee, Jiandong Zhou, Carlin Chang, Tong Liu, Dong Chang, Wing Tak Wong, Keith SK Leung, Abraham KC Wai, Bernard Man Yung Cheung, Gary Tse, View ORCID ProfileQingpeng Zhang
doi: https://doi.org/10.1101/2021.01.04.21249211
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Sharen Lee
1Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China
Jiandong Zhou
2School of Data Science, City University of Hong Kong, Hong Kong, China
MSCarlin Chang
3Division of Neurology, Department of Medicine, The Queen Mary Hospital, Hong Kong, China
MPhil MRCPTong Liu
4Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
MD PhDDong Chang
5Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China
MD PhDWing Tak Wong
6School of Life Sciences, State Key Laboratory of Agrobiotechnology (CUHK), The Chinese University of Hong Kong, Hong Kong, China
PhDKeith SK Leung
7Emergency Medicine Unit, The University of Hong Kong, Pokfulam, Hong Kong, China
BScAbraham KC Wai
7Emergency Medicine Unit, The University of Hong Kong, Pokfulam, Hong Kong, China
MBChB FRCEM FRCPBernard Man Yung Cheung
8Division of Clinical Pharmacology and Therapeutics, Department of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China
MBBChir PhD FRCPGary Tse
5Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China
PhD FRCP FFPHQingpeng Zhang
1Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology, Hong Kong, China
PhD
- Supplementary Appendix[supplements/249211_file02.docx]
Posted January 05, 2021.
Comparative effects of sodium glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP4) inhibitors on new-onset atrial fibrillation and stroke outcomes
Sharen Lee, Jiandong Zhou, Carlin Chang, Tong Liu, Dong Chang, Wing Tak Wong, Keith SK Leung, Abraham KC Wai, Bernard Man Yung Cheung, Gary Tse, Qingpeng Zhang
medRxiv 2021.01.04.21249211; doi: https://doi.org/10.1101/2021.01.04.21249211
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (722)
- Anesthesia (214)
- Cardiovascular Medicine (3067)
- Dermatology (259)
- Emergency Medicine (460)
- Epidemiology (12996)
- Forensic Medicine (13)
- Gastroenterology (857)
- Genetic and Genomic Medicine (4806)
- Geriatric Medicine (443)
- Health Economics (749)
- Health Informatics (3043)
- Health Policy (1100)
- Hematology (406)
- HIV/AIDS (954)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (497)
- Neurology (4582)
- Nursing (243)
- Nutrition (680)
- Oncology (2377)
- Ophthalmology (671)
- Orthopedics (267)
- Otolaryngology (332)
- Pain Medicine (299)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1235)
- Primary Care Research (516)
- Public and Global Health (7161)
- Radiology and Imaging (1592)
- Respiratory Medicine (941)
- Rheumatology (458)
- Sports Medicine (400)
- Surgery (507)
- Toxicology (64)
- Transplantation (218)
- Urology (188)